Home  |  About us  |  Editorial board  |  Current issue  |  Archives  |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 576Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Regulations and guidelines governing stem cell based products: Clinical considerations

George Bobby

Year : 2011| Volume: 2| Issue : 3 | Page no: 94-99

   This article has been cited by
1 The potential impact of bone tissue engineering in the clinic
Ruchi Mishra,Tyler Bishop,Ian L Valerio,John P Fisher,David Dean
Regenerative Medicine. 2016; 11(6): 571
[Pubmed]  [Google Scholar] [DOI]
2 Microparticles to enhance delivery of drugs and growth factors into wound sites
Sanjeev Ranjan,Flavia Fontana,Hanif Ullah,Jouni Hirvonen,Hélder A Santos
Therapeutic Delivery. 2016; 7(10): 711
[Pubmed]  [Google Scholar] [DOI]
3 Evaluating the Safety of Somatic Periosteal Cells by Flow-Cytometric Analysis Monitoring the History of DNA Damage
Tomoyuki Kawase,Kazuhide Hayama,Makoto Tsuchimochi,Masaki Nagata,Kazuhiro Okuda,Hiromasa Yoshie,Douglas M. Burns,Koh Nakata
Biopreservation and Biobanking. 2016;
[Pubmed]  [Google Scholar] [DOI]
4 Insight on stem cell preconditioning and instructive biomaterials to enhance cell adhesion, retention, and engraftment for tissue repair
Muhammad Shafiq,Youngmee Jung,Soo Hyun Kim
Biomaterials. 2016; 90: 85
[Pubmed]  [Google Scholar] [DOI]
5 Endpoints in stem cell trials in ischemic heart failure
Marko Banovic,Zlatibor Loncar,Atta Behfar,Marc Vanderheyden,Branko Beleslin,Andreas Zeiher,Marco Metra,Andre Terzic,Jozef Bartunek
Stem Cell Research & Therapy. 2015; 6(1)
[Pubmed]  [Google Scholar] [DOI]
6 Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis
Marek Barczyk,Matthias Schmidt,Sabrina Mattoli
Stem Cell Reviews and Reports. 2015; 11(4): 598
[Pubmed]  [Google Scholar] [DOI]
7 X-ray and ultraviolet C irradiation–induced ?-H2AX and p53 formation in normal human periosteal cells in vitro: markers for quality control in cell therapy
Tomoyuki Kawase,Mana Kamiya,Kazuhide Hayama,Masaki Nagata,Kazuhiro Okuda,Hiromasa Yoshie,Douglas M. Burns,Makoto Tsuchimochi,Koh Nakata
Cytotherapy. 2014;
[Pubmed]  [Google Scholar] [DOI]
8 Cellular reprogramming for understanding and treating human disease
Riya R. Kanherkar,Naina Bhatia-Dey,Evgeny Makarev,Antonei B. Csoka
Frontiers in Cell and Developmental Biology. 2014; 2
[Pubmed]  [Google Scholar] [DOI]
9 The regulatory sciences for stem cell-based medicinal products
Bao-Zhu Yuan,Junzhi Wang
Frontiers of Medicine. 2014;
[Pubmed]  [Google Scholar] [DOI]
10 Stem Cells, Dot-Com
B. A. Liang,T. K. Mackey
Science Translational Medicine. 2012; 4(151): 151cm9
[Pubmed]  [Google Scholar] [DOI]
11 Peptidhydrogele für den Einsatz von Stammzellen in der regenerativen Medizin
C.A.E. Hauser,Y.E. Loo
Gynäkologische Endokrinologie. 2012; 10(4): 255
[Pubmed]  [Google Scholar] [DOI]


Read this article